NEWS and OPINIONS
Healthspan Action Coalition and Kitalys Institute Propose Landmark Legislation to Promote Healthy Longevity
“An important step towards slowing aging and the onset of major age-related chronic diseases” Washington, DC and San Francisco, CA, March 27, 2025— The Healthspan Action Coalition (HSAC) and the Kitalys Institute jointly proposed today the initial draft of a bill...
Probing the Mysteries of the Aging Brain
By Dennis Nealon - Harvard Research - Research led by new faculty member Michael Segel focuses on mammalian lifespans Sixteen years ago, Michael Segel was a rising senior at Brookline High School in Massachusetts when, acting on a friend’s suggestion, he signed on for...
Cells That Build Themselves Into an Embryo? Scientists Just Made It Happen
By University of California - Santa Cruz - SciTechDaily - Scientists have found a way to study early embryonic development without real embryos. Using CRISPR, they programmed stem cells to self-organize into structures mimicking early embryos. The cells show...
Will Stem Cell Clinics Flourish Under RFK Jr.?
By by Rachael Robertson MedPageToday - After HHS Secretary Robert F. Kennedy Jr. hosted a roundtableopens in a new tab or window on reducing regulations on stem cells earlier this month, experts have raised concerns about a potential flourishing of questionable stem...
Clinical Trial Tests Novel Stem Cell Treatment for Parkinson’s Disease
By Technology Networks - Reprogrammed stem cells to replace dopamine cells in the brain may offer hope for Parkinson's treatment. A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment...
Clinical Trial Tests Novel Stem-Cell Treatment for Parkinson’s Disease
By Mass General Brigham - A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem cells are reprogrammed to replace dopamine...
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
By Frank Vinluan - MedCity News - Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder. Protein therapies...
Scientists create universal vascular graft with stem cells to improve surgery for cardiovascular disease
by Morgridge Institute for Research - MedicalXpress - Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and regenerative...
New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers
by Laura Kelley - University of Colorado Cancer Center - Researchers at CU Anschutz Medical Campus have developed ALA-CART, a next-generation therapy aimed at improving outcomes for patients with resistant cancers. “This next-generation approach, called ALA-CART...
Stem Cell Transplant for Wet Age-Related Macular Degeneration Clears Clinical Study
By Technology Networks - A new, alternative treatment for wet AMD involves the transplantation of stem cell-derived retinal cells. Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population. In so-called wet...
Breathing new life: Working toward an inhalable gene therapy for cystic fibrosis
By UCLA News - UCLA researchers are developing a gene-editing platform that aims to correct the root cause of the disease Imagine a future where treating cystic fibrosis is as simple as taking a deep breath. That’s exactly what a team of pediatric physician-scientists...
CRISPR-based test offers faster, more accurate diagnosis for fungal pneumonia
By Tulane University - MedicalXpress - Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP)—a life-threatening fungal infection primarily affecting children and immunocompromised patients—more quickly...